Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Metastron

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BackgroundAlthough the use of Sr-89 chloride in the treatment of patients with prostate and breast cancer has been widely… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2001
2001
  • Phyllis Windsor
  • Clinical oncology (Royal College of Radiologists…
  • 2001
  • Corpus ID: 8826307
An analysis of prospectively collected data from 75 patients with bone metastases secondary to prostate cancer who were treated… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Abstract. This retrospective study evaluated the toxicity and efficacy of strontium-89 chloride (Metastron, Amersham) in 94… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 3
Is this relevant?
Review
2000
Review
2000
  • A. J. Mcewan
  • Seminars in radiation oncology
  • 2000
  • Corpus ID: 26015902
Pain palliation with bone-seeking radiopharmaceuticals is an effective and cost-effective management tool in patients with… Expand
Is this relevant?
1998
1998
Abstract. One hundred and eighteen patients with painful skeletal metastases of malignant diseases (predominantly prostate… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1996
1996
Strontium-89 chloride (Metastron) is an FDA-approved treatment for palliation of cancer pain. We evaluated blood count changes… Expand
Is this relevant?
1994
1994
A retrospective study was performed on the cost-effectiveness of treatment for advanced prostate cancer metastatic to bone… Expand
Is this relevant?
Review
1994
Review
1994
Bone metastases that develop in patients with advanced prostate cancer often cause deep, unremitting pain. Palliative options for… Expand
Is this relevant?
1994
1994
The objectives of the study were to estimate the cost of medical care for patients recruited into the Trans Canada trial of… Expand
Is this relevant?
1993
1993
In a multicenter, randomized controlled trial involving 126 patients with endocrine-resistant advanced prostate cancer, all of… Expand
Is this relevant?